Active, not recruitingPhase 2NCT01903330

ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme

Studying Gliosarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Epitopoietic Research Corporation
Principal Investigator
Daniela A. Bota, MD, PhD
University of California, Irvine
Intervention
ERC1671(drug)
Enrollment
84 enrolled
Eligibility
18 years · All sexes
Timeline
2014 – 2026

Study locations (3)

Collaborators

University of California, Irvine

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01903330 on ClinicalTrials.gov

Other trials for Gliosarcoma

Additional recruiting or active studies for the same condition.

See all trials for Gliosarcoma →

← Back to all trials